Who We Are

BioMed is a multispecialty clinical research organization that specializes in the startup, execution, and management of clinical trials.


We are a dedicated, diverse team of professionals, who are passionate about delivering results to our customers and partners.


Together, we work as one, with speed, excellence and a passion to succeed, in order to deliver therapies that save lives and improve quality of life.

VIEW OUR SERVICES

PHASE I-IV CLINICAL RESEARCH SOLUTIONS TAILORED TO HELP YOU DELIVER LIFE-CHANGING THERAPIES SUCCESSFULLY WITH SPEED AND EFFICIENCY


Our end-to-end solutions—full-service, often customized strategies—cover every aspect of clinical testing. Our experienced team takes pride in its ability to consult and plan for every step of developing and testing medical therapies. We use our expertise and resources as an efficient CRO to help you advance your drug development program.

BioMed experts consider the end before the beginning by envisioning and planning for commercialization and market acceptance well before the first patient is enrolled in a clinical trial. And as testing is underway, we design for post-approval, real-world patient observation that may lead to new ideas and products.

We have networks of investigators, clinicians, patients and testing sites across the globe. We tap our regulatory expertise, data and business analytics, and proven laboratory services to work effectively with pharmaceutical, biotech, medical device, academic, government and public health organizations in clinical testing.

We understand that each customer has unique needs and work to design innovative, custom solutions across the full drug development life cycle.

Patients First 

At BioMed we don't view our patients as merely subjects for generating data, but as informed collaborators whose participation is core to the overall success of clinical trials. 


Through collaboration, each of us at BioMed, strives to change the corporate culture and trial design, by leveraging our expertise, positive impact and our understanding of patient needs to conduct patient-centric clinical trials.


We maximize our diverse expertise to adopt patient-centered drug, device and therapy development that puts our patients first, no matter what, all the time.

Inovation

At BioMed we focus on large scale transformation initiatives that are cross-functional and aim at achieving specified outcomes.


We adopt adaptive trial designs that afford us the ability to execute novel tools and methodologies, flexible and dynamic designs, new infrastructures, that deliver Model-Based therapies. This has proven to be very useful in the selection of a treatment or a dosing regimen that optimizes the target clinical benefit while minimizing undesirable adverse effects.


Consequently, this improves efficiency, reduce costs and timelines. Additionally, it makes better use of available resources. Thereby, increasing confidence and safeguarding our integrity and the integrity of our clinical trials.

Leadership

We foster a culture of inclusion and collaboration at our company. Our employees, with their diverse backgrounds and expertise, are encouraged to connect and work together as a global team. We value unique perspectives and treat each other with dignity and respect. By actively seeking to enhance our culture of diversity and inclusion, we believe that encouraging employees to share their ideas and opinions ultimately strengthens the company and contributes to its growth.


Redefining Clinical Research Excellence


Committed to pioneering advancements in clinical research and advancing the future of healthcare, we provide unmatched support and innovative solutions to ensure excellence in clinical trials.




CONTACT US

With quick and accurate responses to all your queries, you’ll save time and be more efficient.






Our support team is here to ensure that things run smoothly, so you can focus elsewhere. 




Grow your business

Watch your profits and efficiency soar. You’ll expand faster than you ever thought possible. 



Share by: